Frontlight ResearchEarly access
TerminatedPhase 1
First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)
Key facts
- Who runs it
- Asahi Kasei Therapeutics Corporation
- Where
- Canada7 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- Phase
- Phase 1
- People taking part
- 30 people enrolled
- Started
- 18 Nov 2020
- Ended
- 30 Jan 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- AK1320 MS
- Control
- Record updated
- 6 March 2024
- Why it stopped
- Sponsor decision
Who can take part
- Age
- 22 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Involved level L1 to S1
- Use of local autologous bone only
- Degenerative spondylolisthesis up to Meyerding's Classification Grade 1 or 2
- Moderate or higher disability as assessed by Oswestry Disability Index
- Neurogenic claudication and/or radiculopathy with or without back pain
- Male or female over 22 years of age and less than 81 years of age
Who cannot take part
- Prior lumbar decompression or spine fusion attempt (any level)
- Undergoing concurrent interbody fusion
- Requires spinal fusion at more than one lumbar level
- Degenerative scoliosis
- BMI > 40
- Radiographically confirmed significant spinal instability
- Active or recent (within the past two (2) years) worker's compensation litigation
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The safety and efficacy of AK1320 MS will be evaluated in patients with degenerative spondylolisthesis and concomitant symptomatic spinal stenosis who are undergoing decompression and single level instrumented posterolateral lumber autograft fusion surgery.
The 2 groups in the trial
- AK1320 MSTreatment being tested
AK1320 MS + Local Autologous Bone + Posterior Fixation
- ControlOther group
Local Autologous Bone + Posterior Fixation
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery
- Record updated
- 6 March 2024